Lymphopenia in Wegener's granulomatosis: A new clinical activity index?

Nephron

Volumn 92, Issue 2, 2002, Pages 466-471

  Izzedine, Hassane ^a   Cacoub, Patrice ^a   Launay Vacher, Vincent ^a   Bagnis, Corinne ^a   Deray, Gilbert ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Disease activity; Lymphopenia; Wegener granulomatosis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; LUNG HEMORRHAGE; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; PRIORITY JOURNAL; RELAPSE; REMISSION; RETROSPECTIVE STUDY; WEGENER GRANULOMATOSIS;

ADULT; AGED; FEMALE; HUMANS; LYMPHOCYTE COUNT; LYMPHOPENIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; WEGENER GRANULOMATOSIS;

EID: 0036418877     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063303     Document Type: Article

References (21)

1. Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
2. Girard T, Mahr A, Noel LH, Cordier JF, Lesavre P, Andre MH, Guillevin L: Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study. Rheumatology 2001;40: 147-151.
3. Zhang X. Jiang M, Chui J, Wang H, Ma J: Detection of antineutrophil cytoplasmic antibodies for the values of Wegener's granulomatosis diagnosis and activity judgment. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1997;19: 284-287.
4. Gordon M, Luqmani RA, Adu D, Greaves I, Richards N, Michael J, Emery P, Howie AJ, Bacon PA: Relapses in patients with a systemic vasculitis. Q J Med 1993;86:779-789.
5. Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, Specks U, Allen NB, Davis JC, Spiera RF, Calabrese LH, Wigley FM, Maiden N, Valente RM, Niles JL, Fye KH, McCune JW, St Clair EW, Luqmani RA: A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 2001;44: 912-920.
6. Kallenberg CGM, Cohen T, Stegeman CA: Criteria for disease activity in Wegener's granulomatosis: A requirement for longitudinal clinical studies. APMIS Suppl 1990;19:37-39.
7. Watts RA, Carruthers DM, Scott DG: Epidemiology of systemic vasculitis: Changing incidence or definition? Semin Arthritis Rheum 1995;25:28-34.
8. Hoffman GS, Kerr GS, Leavitt RY, Hallaham CW: Wegener's granulomatosis: An analysis of 158 patients. Ann Intern Med 1992;116:488-498.
9. Rheinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A, Duncker G, Gross WL: Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum 1994;37:919-924.
10. Anderson G, Coles ET, Crane M, Douglas AC, Gibbs AR, Geddes DM, Peel ET, Wood JB: Wegener's granuloma: A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J Med 1992;83: 427-438.
11. Nolle B, Specks U, Ludemann J, Rohrbach MS, DeRemee RA, Gross WL: Anticytoplasmic autoantibodies: Their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med 1989;111:28-40.
12. De Groot K, Gross WL: Wegener's granulomatosis: Disease course, assessment of activity and extent and treatment. Lupus 1998;7:285-291.
13. Fienberg R, Mark EJ, Goodman M, McCluskey RT, Niles JL: Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis. Hum Pathol 1993;24:160-168.
14. Schmitt WH, Heesen C, Scernok E, Rautmann A, Gross WL: Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis: Association with disease activity. Arthritis Rheum 1992;35:1088-1096.
15. Mrowka C, Sieberth HG: Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: Marked differences between Wegener's granulomatosis and systemic lupus erythematosus. Clin Invest 1994;72:762-768.
16. Brown KA: Nonmalignant disorders of lymphocytes. Clin Lab Sci 1997;10:329-335.
17. Castelino DJ, McNair P, Kay TW: Lymphocytopenia in a hospital population - What does it signify? Aust N Z J Med 1997;27:170-174.
18. Meibohm B, Derendorf H, Mollmann H, Frohlich P, Tromm A, Wagner M, Homrighausen S, Krieg M, Hochhaus G: Mechanism-based PK/PD model for the lymphocytopenia induced by endogenous and exogenous corticosteroids. Int J Clin Pharmacol Ther 1999;37:367-376.
19. Tornatore KM, Venuto RC, Logue G, Davis PJ: CD4+ and CD8+ lymphocytes and cortisol response patterns in elderly and young males after methylprednisone exposure. J Med 1998; 29:159-183.
20. Kindt X, Reumaux D, Bridoux F, Tribout B, Bataille P, Hachulla E, Hatron PY, Duthilleul P, Vanhille P: Serial measurements of antineutrophil cytoplasmic antoantibodies in patients with systemic vasculitis. Am J Med 1999;106: 527-533.
21. Galperin C, Hoffman GS: Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis and other disease: Clinical issues. Cleve Clin J Med 1994;61:416-427.